Versameb AG

https://www.versameb.com

Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNA molecules for customized protein expression and modification in multiple disease areas with high unmet medical need. *

	Start	2018-01-30 existent
	Industry	VERSagile mRNA technology platform
	Industry 2	mRNA-based drug
	Person	Metzger, Friedrich (Versameb 201910 CEO)
	Person 2	Ferreira, Isabel (Versameb 201910c– CBO before Roche Partnering + Prosensa)

	Region	Basel BS
	Country	Switzerland
	Street	60C Hochbergerstr.
	City	4057 Basel BS
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Versameb AG. (10/17/19). "Press Release: Versameb Raises CHF 6.4 Million in Seed C Round and Strengthens the Team". Basel.

		Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Versameb AG

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]